Which Lots Of Losartan Are Recalled

More Losartan Lots Recalled. Instructions for. has expanded its recall of losartan potassium and losartan potassium. Hetero recalled 87 lots of losartan potassium tablets that were distributed by Camber Pharmaceuticals in 25mg, 50mg and 100mg dosages. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. Health Canada says Losartan, an active pharmaceutical ingredient in the. I'm taking Losartan BP meds. The recalled drugs include specific lots of Apo-Losartan, Apo-Losartan/HCTZ, Losartan, PMS-Losartan, and Teva-Losartan/HCTZ. The recalled medications include specific “lots” of losartan, irbesartan, valsartran and combination drugs with valsartran. The recall noted that Camber has not received any reports of adverse events related to the recall. (Gray News) - Torrent Pharmaceuticals has expanded the recall of losartan potassium to include eight additional lots, according to the Food and Drug Administration. In July of 2018, the FDA made a series of voluntary recalls of several versions of the generic blood pressure medication valsartan which were made in China and were contaminated by the “possible carcinogen,” N-nitrosodimethylamine (NDMA). • Anyone with an existing inventory of the recalled product should stop use and distribution, and quarantine the product immediately. on Thursday recalled 87 lots of losartan that contained small amounts of N-Nitroso N-Methyl 4-amino butyric acid,. Since then, more information has come to light and other medications, including batches of losartan and irbesartan, have also been recalled. This recall was prompted due to Camber. , and Pro Doc Limitée are voluntarily recalling multiple lots of Losartan-containing products as a precaution. The FDA expects that in six months, the manufacturing issue will be solved and that many companies will be able to manufacture losartan without any impurities. Losartan Latest BP Drug Recalled for Contamination. Losartan Recall Lawsuit. Patients taking the recalled tablets are advised. But these two i take now are the only ones that seem to help with my bp to keep it normal. Vivmed Life Sciences recalled 19 lots of Losartan Potassium tablets made for distributor Heritage Pharmaceuticals, which operates out of East Brunswick, NJ. (CNN) - The recall of popular heart drugs has expanded yet again. Vivimed Life Sciences produced the medication and Heritage Pharmaceuticals distributed them. dba Solco Healthcare LLC. Based in Mumbai, Macleods’ tablets were manufactured by Hetero Labs in Hyderabad, India. Torrent Pharmaceuticals Ltd. If you take blood pressure medicine, you'll want to double-check your bottle. Prinston Pharmaceuticals has recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ, the company announced in a news release. The recalled tablets, made by Hetero Labs Ltd. is recalling 40 lots of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, as well as three repackaged lots of Losartan Potassium Tablets, USP, 50 mg. has initiated a voluntary recall in the United States of 35 lots of bulk Losartan Potassium USP Tablets. Macleods Pharmaceuticals Limited, which recalled a lot of losartan in February, recalled 32 lots of Losartan Potassium tablets because the amount of impurity NMBA exceeded FDA standards. • Anyone with an existing inventory of the recalled product should stop use and distribution, and quarantine the product immediately. Torrent Pharmaceuticals Limited said Thursday it would be recalling 36 more lots of Losartan potassium tablets USP and 68 more lots of Losartan potassium/hydrochlorothiazide tablets due to the. Blood Pressure Drug Losartan Recalled Due to Contamination CODES Apr 19, 2019 · If you are taking the popular blood pressure drug, losartan, you may have seen the news reports about contamination. Canada/Ottawa: Golden Boy Foods Ltd. In 2016 alone, manufacturers recalled 4,448 drug and device products, according to the Center for Devices and Radiological Health and the Center for Drug Evaluation and Research. The company said in the statement that for this recall "it has not received any reports of adverse effects. (Gray News) - Torrent Pharmaceuticals has expanded the recall of losartan potassium to include eight additional lots, according to the Food and Drug Administration. To provide better service in alerting the American people to unsafe, hazardous or defective products, six federal agencies with vastly different jurisdictions have joined together to create www. The affected lots are being recalled due to an unexpected impurity in the manufacturers' active pharmaceutical ingredient (API). Torrent and Hetero/Camber are only recalling lots of losartan-containing medication with NMBA above the interim acceptable intake limits of 0. The recall covers 25 mg, 50 mg and 100 mg dosages. Trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA), which has been classified as a. Hetero Labs Ltd. The recall is the latest in an ongoing investigation into a class of drugs known as angiotensin receptor blockers or ARBs, which contain either valsartan, losartan or irbesartan and are used in patients with high blood pressure and other conditions. Recalled losartan medicines. The recall, to the patient level, is due to the detection of the probable carcinogen N-Methylnitrosobutyric. May 7, 2019 – Vivimed Life Sciences has issued a nationwide recall for 19 lots of losartan potassium tablets over concerns the product may be contaminated with N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), an impurity that has been linked to an increased risk for cancer, according to an FDA Recall Notice issued on Friday. Please complete all the fields below to send the bad drug report. I have problems with other meds before. Through its surveillance system, the DH noted that Health Canada (the Canadian regulatory authority) is advising that multiple lots of losartan-containing products are being voluntarily recalled because of the potential for an impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). To see a list of all the lots involved in the recall, please click here. Of those, 29 lots were 100mg strength while six lots were 25mg strength. The company first recalled two. Legacy Pharmaceutical Packaging issued two company announcements March 15, saying in one that it was recalling 40 repackaged lots of losartan tablets in 25-milligram, 50-mg, and 100-mg dose due to. Vivmed Life Sciences recalled 19 lots of Losartan Potassium tablets made for distributor Heritage Pharmaceuticals, which operates out of East Brunswick, NJ. (KPLC) - Two more hypertension medications have been recalled due to a possible process impurity or contaminant in an active pharmaceutical ingredient, according to the FDA. A pharmaceutical company voluntarily recalls lots of Losartan potassium tablets after it has found an impured substance, which a cancer research agency classifies as a "probable human carcinogen Torrent Pharmaceuticals Limited recently released an announcement, which the Food and Drug Administration. In 2016 alone, manufacturers recalled 4,448 drug and device products, according to the Center for Devices and Radiological Health and the Center for Drug Evaluation and Research. has expanded its recall of losartan potassium and losartan potassium. Torrent Pharmaceuticals Ltd. The FDA issued an import alert in September to block products made at the China plant from entering America and issued a warning letter in November about challenges including impurity control. Macleods also recalled one lot of the losartan combination drug in February for the same reason. The recall covers 25 mg, 50 mg and 100 mg dosages. News ; RECALL: 87 lots of Losartan Potassium Camber Pharmaceuticals is voluntarily recalling 87 lots of a drug used to treat blood pressure and congestive heart failure. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. Recall of 32 lots of the popular blood pressure drug Losartan after discovering trace amounts of a probable carcinogen. , Pharmascience Inc. 9% Sodium Chloride 100 mg bag. The recalled losartan and potassium/hydrochlorothiazide combination tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according to a company notice posted to the Food and. The recalled lot of enalapril/HCTZ 10 mg/25 mg tablets started shipping over a year ago, on February 13, 2014. The company is recalling 36 additional lots, it said Thursday, April 18. The recall covers 25 mg, 50 mg and 100 mg dosages. 26/06/2019 · Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. The recall marks the first for NMBA and the third type of nitrosamine impurity discovered in sartan blood pressure meds, following the discovery of NDMA and NDEA. Blood pressure medication recall expands again with new lots of Losartan. On May 6, 2019, the FDA announced a recall of 19 lots of Vivimed (Heritage is the supplier) losartan potassium products because of NMBA levels of greater than 9. The US Food and Drug Administration said Thursday that Torrent Pharmaceuticals has added eight additional lots of losartan potassium tablets to its recall list. Camber Pharmaceuticals, Inc. One of the raw ingredients, losartan, USP, made by Zhejiang Huahai Pharmaceutical Co. (KPLC) - Two more hypertension medications have been recalled due to a possible process impurity or contaminant in an active pharmaceutical ingredient, according to the FDA. (Gray News) - Torrent Pharmaceuticals has expanded the recall of losartan potassium to include eight additional lots, according to the Food and Drug Administration. The affected product was not distributed prior to Oct. The submission of this form does not form an attorney client relationship. But these two i take now are the only ones that seem to help with my bp to keep it normal. A couple of days ago the US Food and Drug Administration (USFDA) in a statement said: "Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, USP to the. Jennie-O Turkey Store Sales, LLC, a Barron, Wis. com A recall of Torrent Pharmaceuticals Limited’s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. 43 lots in total have been recalled. Image: Teva Pharmaceuticals USA has recalled Losartan Potassium 25mg and 100mg Tablets USP. OTTAWA, March 9, 2019 /CNW/ - Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc. Losartan is a medication used to treat hypertension. Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. Separately, Legacy Pharmaceutical Packaging has recalled three additional repackaged lots of losartan tablets (50 mg, 30-count bottles) to the consumer level. 43 lots in total have been recalled. Teva Pharmaceuticals has expanded its voluntary recall of losartan potassium tablets after detecting a possible human carcinogen in the blood pressure medication. are recalling all lots of non-expired valsartan-containing products supplied by this third-party supplier. The company first recalled two lots of the drug last month. Torrent Pharmaceuticals Limited is notifying its distributors and customers by phone and in writing to immediately discontinue distribution of the specific lots being recalled and to notify their sub-accounts. (Gray News) - Torrent Pharmaceuticals has expanded the recall of losartan potassium to include eight additional lots, according to the Food and Drug Administration. A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, 2018. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. The US Food and Drug Administration said Thursday that Torrent Pharmaceuticals has added eight additional lots of losartan. (KPLC) - Two more hypertension medications have been recalled due to a possible process impurity or contaminant in an active pharmaceutical ingredient, according to the FDA. The company is recalling 36 additional lots, it said Thursday. Heads up for people who take the blood pressure drug Losartan. I take Losartan, but my pharmacy claims i have nothing to worry about. This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9. The most recent find is 10 lots of losartan from Teva made with a tainted API from Hetero Labs. Camber Pharmaceuticals, Inc. Be sure to share this with your family and friends. As of November 8, 2018, drug manufacturer Sandoz Inc. The recalled tablets, made by Hetero Labs Ltd. is recalling 87 lots of the blood pressure medication losartan to the consumer level after discovering contamination with a potential carcinogen (cancer-causing substance). The voluntary recall began with two lots of Losartan potassium tablets USP on Jan. separate lots of ARB blood pressure and heart failure medications from various companies were recalled around the. The Losartan active pharmaceutical ingredient (API) in all of the recalled products is manufactured by Hetero Labs Ltd. The company first recalled two lots of the drug last month. Blood Pressure Medication Recalls. More blood pressure tablets recalled due to possible cancer. in India and distributed by Camber. voluntarily recalled 87 lots of losartan tablets in the United States on Thursday. in India has recalled 87 lots of losartan potassium tablets (25mg, 50mg and 100mg) due to detection of the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), which is a known animal and potential human carcinogen. The drugs were made in India and distributed. If you take blood pressure medicine, double-check your prescription. Beginning in July, several lots of the ARB drug valsartan were recalled after NDMA was detected in various brands. Mylan Pharmaceuticals was aso among the group who issued voluntary recalls, this time over their Amlodipine and Valsartan products. has recalled 87 lots of Losartan Tablets USP. The recalled losartan potassium tablets made by Hetero Labs and distributed by Camber Pharmaceuticals contain the impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). , Pharmascience Inc. Health Canada is advising Canadians that multiple lots of losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc. The recall is due to an "impurity" that is. Food and Drug. It says the lots can contain amounts of N-Nitrosodiethylamine, or NDEA, above the federally acceptable intake level of 0. (FDA)– Legacy Pharmaceutical Packaging, LLC is recalling 43 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. Losartan potassium is a drug used to control high blood pressure. Camber and Macleods voluntarily recalled losartan tablet lots after trace amounts of NDEA were found, in March 2019. Bahureksa on losartan potassium warnings and recalls: B"sd as far as meds thiazide diuretics decrease urine and increase blood calcium. This recall stems from Torrent Pharmaceuticals' previously announced nationwide recall of losartan due to detection of trace amounts of NMBA manufactured by Hetero Labs. The tablets had too much NMBA, which. i now take two and one of them is Losartan. Image: Teva Pharmaceuticals USA has recalled Losartan Potassium 25mg and 100mg Tablets USP. For questions regarding returns, please contact Stericycle at 1-877-523-9106. In India and distributed by Camber Pharmaceuticals, were found to contain trace amounts of the impurity. Torrent Pharmaceuticals announced an initial recall on December 20 after finding NDEA in 2 lots of the active ingredient manufactured by Hetero Labs Limited. • NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International. "The risk of. Torrent's products are being recalled due. The company recalled losartan potassium tablets, USP, in 25 mg, 50 mg, and 100 mg doses. The amount of NMBA contained in the recalled lots exceeded the amount permitted by the FDA. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). The tablets, which have been packaged and sold by Golden State Medical Supply, will be recalled from their customers and patients. I have problems with other meds before. 43 lots in total have been recalled. 9% Sodium Chloride Recalled by SCA Pharmaceuticals for Precipitate For visible particulate matter believed to be furosemide precipitate, SCA Pharmaceuticals is voluntarily recalling 7 lots of the injectable product Furosemide 100 mg in 0. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. The drugs are packaged with 3 to 10 tablets per blister card. It is freely soluble in water, soluble in alcohols, and slightly soluble in common organic solvents, such as acetonitrile and methyl ethyl ketone. Legacy Pharmaceutical Packaging LLC. They are from 4 manufacturers (I checked because I take it); Camber, Sandoz, Macleods and Torrent. Macleods Pharmaceuticals Limited, which recalled a lot of losartan in February, recalled 32 lots of Losartan Potassium tablets because the amount of impurity NMBA exceeded FDA standards. In April 2019, Torrent expanded their voluntarily recall to 36 lots of losartan potassium tablets and 68 lots of losartan potassium - hydrochlorothiazide. (2019, March 1). The company has now recalled 10 lots. Patients who have been using Losartan since 2012 may experience complications due to manufacturing contamination. , and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-nitroso-N-methyl-4-aminobutyric acid (NMBA). Important recall notice Losartan and Losartan with Hydrochlorothiazide recall (Torrent) After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. However, the company has voluntarily recalled 36 additional lots of losartan potassium and 68 lots of losartan potassium/hydrochlorothiazide tablets that contain impurity levels that are higher. RECALLED PRODUCT: Product Description NDC Number Affected Lots Expiration Date Losartan potassium 100mg tablets 30 count bottles 13668-0115-30 BO31C016 04/2019 Losartan potassium 100mg tablets 90 count bottles 13668-0115-90 BO31C016 04/2019 Losartan potassium 100mg tablets 1,000 count bottles 13668-0115-10 4DK3C005 04/2019. Torrent Pharmaceutical Limited recalled a total of 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tabs after detection of trace amount of N-Methyl Nitroso Butyric acid, also known as NMBA for short. Now, additional lots of losartan- and irbesartan-containing products are being recalled. READ MORE. Our lawyers are filing lawsuits for people who were harmed by the side effects of losartan, a blood pressure medication that has been recalled by several companies after being found to be contaminated with a carcinogenic (cancer-causing) substance. is recalling 40 lots of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, as well as three repackaged lots of Losartan Potassium Tablets, USP, 50 mg. Teva Pharmaceuticals has expanded its voluntary recall of losartan potassium tablets after detecting a possible human carcinogen in the blood pressure medication. I have problems with other meds before. No adverse effects related to these recalled hypertension drugs have been reported. LAKE CHARLES, LA (KPLC) - Torrent Pharmaceuticals Limited is expanding its voluntary recall of Losartan potassium tablets USP for the second time, according to the FDA. The recalled tablets, made by Hetero Labs Ltd. The recalled lots carry expiration dates from July 2019. News ; RECALL: 87 lots of Losartan Potassium Camber Pharmaceuticals is voluntarily recalling 87 lots of a drug used to treat blood pressure and congestive heart failure. 's losartan potassium hydrochlorothiazide 100 milligram/25 milligram tablets with the lot number JB8912. Drugs containing valsaratan, losartan and. Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include Losartan potassium and hydrochlorothiazide tablets, USP, due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient. Important recall information for Losartan Potassium 100mg Tablets We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. A single-lot recall is in effect for Sandoz Inc. It's the latest in a series of. , in USA, Hetero Europe in Europe, and Richmond Labs in Argentina. The recall covers 25 mg, 50 mg and 100 mg dosages. Camber Pharmaceuticals, Inc. Prinston Pharmaceuticals has recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ, the company announced in a news release. I have problems with other meds before. The recall is expanded to include an additional 36 lots of losartan potassium tablets USP and 68 lots of losartan potassium /hydrochlorothiazide tablets, USP. NDEA is a naturally occurring substance that has been classified as a probable human carcinogen by the International Agency for Research on Cancer. Macleods Pharmaceuticals Limited is voluntarily recalling 32 lots of Losartan tablets. 32 lots are being recalled due to containing N-nitrosodiethylamine or NDEA according to the company notice that was published to the FDA website on Wednesday. If you are taking the popular blood pressure drug, losartan, you may have seen the news reports about contamination. Macleods is recalling 32 lots of generic losartan and losartan/HCTZ tablets due to the presence of NMBA, a potentially cancer-causing impurity. Camber Pharmaceuticals Inc. Update [5/6/2019] FDA is alerting patients and health care professionals to a voluntary recall of 19 lots of losartan potassium tablets made by Vivimed Life Sciences Pvt Ltd in Alathur, Chennai. (CNN) — If you take blood pressure medicine, you’ll want to double-check your bottle. Recall Alert: Losartan potassium tablets recalled Torrent Pharmaceuticals Limited has increased the company’s recent recall of Losartan potassium tablets USP from two lots to 10 lots. "Medications in the ARB class are used primarily for hypertension and for heart failure, and the. is recalling 40 lots of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, as well. Its empirical formula is C22H22ClKN6O, and its structural formula is: Losartan potassium, USP is a white to off-white free-flowing crystalline powder with a molecular weight of. Lots of losartan could be contaminated with carcinogen Columbus. Torrent Pharmaceuticals Ltd. This recall involves blister packages of prescription drugs from Novartis and Sandoz. The recall covers 25 mg, 50 mg and 100 mg dosages. in India has recalled 87 lots of losartan potassium tablets (25mg, 50mg and 100mg) due to detection of the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), which is a known animal and potential human carcinogen. has recalled 87 lots of Losartan Tablets USP. Health Canada has announced that lots of drugs containing the active ingredient Losartan are being voluntarily recalled by the manufacturers. The Sandoz Inc. The recall was issued because a trace amount of N-Nitroso N-Methyl 4. They are embossed with "LK 25" on one side and ">" on the other. This recall was prompted due to Camber. The company said Losartan is "used to treat hypertension, hypertensive patients with. Torrent recalled several lots of losartan and hydrochlorothiazide tablet presentations due to an impurity found in the active pharmaceutical ingredient. 3 before being expanded. Macleods Pharmaceuticals has recalled 32 lots of losartan potassium tablets after testing uncovered trace amounts of a probable carcinogen. PARSIPPANY, N. Originally the company recalled 10 lots of the medication. , Major Pharmaceuticals, and Prinston Pharmaceutical Inc. Macleods is recalling 32 lots of generic losartan and losartan/HCTZ tablets due to the presence of NMBA, a potentially cancer-causing impurity. The recalled batches contain cancer-linked nitrosamines. Before that, the latest recall expansion involved 36 lots of Losartan Potassium Tablets, USP, and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP, for the same type of contamination. in India has announced a recall of 87 lots of losartan potassium tablets (25 mg, 50 mg and 100 mg). is recalling 40 lots of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, as well. They are from 4 manufacturers (I checked because I take it); Camber, Sandoz, Macleods and Torrent. Losartan, valsartan and irbesartan are the ARB drugs for which specific lots have been recalled. gov -- a "one stop shop" for U. has recalled 50 lots of losartan potassium tablets USP and 54 lots of losartan potassium/hydrochlorothiazide tablets USP. Now company officials have added an additional. Legacy Pharmaceutical Packaging, LLC is expanding its consumer-level recall of 3 repackaged lots Losartan Tablets USP 50mg to include one additional lot. The recalled Novartis prescription blister packages have "Novartis," the name of the drug, dosage, NDC, lot number and expiration date printed on the cartons and the blister cards. The FDA expects that in six months, the manufacturing issue will be solved and that many companies will be able to manufacture losartan without any impurities. Losartan potassium is a drug used to control high blood pressure. Losartan 100mg Tablet Reason Affected lots manufactured with an API that may contain the impurity N-nitroso-N-methyl-4-aminobutyric acid (referred as "NMBA") above the acceptable level. Torrent Pharmaceuticals Ltd. Camber Pharmaceuticals, Inc. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. On April 29, 2019, a recall was issued for 44 lots of Losartan potassium tablets manufactured by Teva Pharmaceuticals and labeled as Golden State Medical Supply due to the detection of NMBA. Doctors give trusted answers on uses, effects, side-effects, and cautions: Dr. Torrent Pharmaceuticals announced an initial recall on December 20 after finding NDEA in 2 lots of the active ingredient manufactured by Hetero Labs Limited. In April 2019, Torrent expanded their voluntarily recall to 36 lots of losartan potassium tablets and 68 lots of losartan potassium - hydrochlorothiazide. The FDA recalled dozens of products that contained Losartan due to an impurity in the active ingredient - the impurity is classified as a probable human carcinogen. More lots of Losartan, a drug used to treat high blood pressure and heart conditions, were recalled due to the presence of a potentially cancer-causing ingredient, said the U. The company first recalled two lots of the drug last month. Additionally, Legacy expanded its recall to include 1 additional lot of Losartan tablets due to the detection of NMBA. Losartan Recall Lawsuit. "Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. exforge hct (amlodipine and hydrochlorothiazide and valsartan) (amlodipine valsartan hydrochlorothiazide tablets) - has thiazide, plain exforge (amlodipine valsartan tablets) does. 20 December 2018 to 03 January 2019 – Torrent Pharmaceuticals recalls two lots of losartan potassium, which is subsequently expanded to 10 lots. 96 parts per million (ppm). Took for 3 years and switched to valsartan, in 2012 Then changed to Losartan potassium last year. Losartan is a prescription drug that has been used to treat heart conditions like hypertension, as well as high blood pressure and ventricle dysfunction. The first recall was issued November 9, 2018 and involved 2 lots. The recall noted that Camber has not received any reports of adverse events related to the recall. the FDA announced Camber Pharmaceuticals is recalling 87 lots of Losartan Tablets USP 25 mg, 50. March 2019 — Camber Pharmaceuticals Inc. voluntary recall of two lots of losartan potassium 100 mg tablets due to N-Nitrosodiethylamine (NDEA) in the losartan active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Legacy Pharmaceutical Packaging LLC. voluntarily recalled 87 lots of losartan tablets in the United States on Thursday. Macleods Pharmaceuticals Limited, which recalled a lot of losartan in February, recalled 32 lots of Losartan Potassium tablets because the amount of impurity NMBA exceeded FDA standards. Torrent Pharmaceuticals Limited is recalling 60 lots of Losartan potassium tablets and 54 lots of Losartan potassium/ hydrochlorothiazide tablets because they contain "N-Methylnitrosobutyric (NMBA. Torrent is only recalling lots of losartan-containing medication containing NDEA above the interim acceptable intake limits of 0. , and Pro Doc Limitée are voluntarily recalling multiple lots of Losartan-containing products as a precaution. 13, 2018 -- Yet another blood pressure drug has been recalled because of fears of impurities added by a lab in China. is recalling 40 lots of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, as well as three repackaged lots of Losartan Potassium Tablets, USP, 50 mg. According to national media outlets, Torrent Pharmaceuticals last April 18 recalled 36 lots of losartan potassium tablets and 68 lots of losartan potassium/hydrochlorothiazide tablets for alleged NMBA contamination. Torrent Pharmaceuticals announced an initial recall on December 20 after finding NDEA in 2 lots of the active ingredient manufactured by Hetero Labs Limited. Several pharmaceutical companies have voluntarily recalled their medications containing valsartan and losartan after it was discovered that the drug may have been tainted with the carcinogen NDMA or NDEA during the manufacturing process. has recalled 87 lots of Losartan Tablets USP. Torrent Pharmaceuticals Ltd. The lot was allegedly contaminated with NDEA, a substance that is a probable human carcinogen. The recalled tablets, made by Hetero Labs Ltd. Its empirical formula is C22H22ClKN6O, and its structural formula is: Losartan potassium, USP is a white to off-white free-flowing crystalline powder with a molecular weight of. Prinston Pharmaceuticals has recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ, the company announced in a news release. Legacy Pharmaceutical Packaging LLC. The FDA issued an import alert in September. 9% Sodium Chloride Recalled by SCA Pharmaceuticals for Precipitate For visible particulate matter believed to be furosemide precipitate, SCA Pharmaceuticals is voluntarily recalling 7 lots of the injectable product Furosemide 100 mg in 0. Torrent Pharmaceuticals Ltd. If you take blood pressure medicine, you'll want to double-check your bottle. 9% Sodium Chloride 100 mg bag. Following a rash of blood pressure medication recalls over the last two months, Camber Pharmaceuticals has also recalled 87 lots of Losartan Potassium tablets USP for the detection of a cancer. 43 lots in total have been recalled. NEW HAVEN, Conn. Torrent Pharmaceuticals Limited has increased the company’s recent recall of Losartan potassium tablets USP from two lots to 10 lots. Harris Teeter of Matthews, NC, is recalling Abound Chicken and Rice Dog Food due to elevated levels of vitamin D. The recall of popular heart drugs has expanded yet again. The recent recall of sartan-based blood pressure medications has been expanded yet again. Macleods Pharmaceuticals Limited, which recalled a lot of losartan in February, recalled 32 lots of Losartan Potassium tablets because the amount of impurity NMBA exceeded FDA standards. com A recall of Torrent Pharmaceuticals Limited’s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. Macleods Pharmaceuticals Limited has issued a voluntary recall of 32 lots of Losartan Potassium USP Tablets and Losartan Potassium/Hydrochlorothiazide combination tablets due to the detection of. Torrent is only recalling lots of losartan-containing products that contain NMBA above the acceptable daily intake levels released by the US Food and Drug Administration (FDA). The drugs have a trace amount of an unexpected impurity. Forty-three more lots of a blood pressure medication have been recalled because of concerns they may contain trace amounts of a potentially cancer-causing impurity. More losartan recalled; attorney projects at least 2K lawsuits will follow. Torrent Pharmaceuticals Limited has increased the company’s recent recall of Losa. Torrent Pharmaceuticals Ltd. The recall is expanding from 10 lots of Losartan potassium tablets USP to include six lots of Losartan potassium and hydrochlorothiazide tablets, USP due to detection of trace amounts of an. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. New Losartan Lots Recalled. Losartan is a prescription medication used to treat high blood pressure and congestive heart failure. Its empirical formula is C22H22ClKN6O, and its structural formula is: Losartan potassium, USP is a white to off-white free-flowing crystalline powder with a molecular weight of. A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, 2018. This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9. Now, additional lots of losartan- and irbesartan-containing products are being recalled. has recalled 87 lots of Losartan Tablets USP. According to the FDA, Legacy Pharmaceutical Packaging has recalled four lots of losartan because the batch contained trace amounts of the nitrosamine, NMBA, which has been linked to increased risk. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N. started the voluntarily recall of Losartan potassium hydrochlorothiazide tablets after further FDA testing. Camber Pharmaceuticals, Inc. Of those, 29 lots were 100mg strength while six lots were 25mg strength. Losartan Recall Lawsuit. The US Food and Drug Administration said Thursday that Torrent Pharmaceuticals has added eight additional lots of losartan. 3 before being expanded. Trace amounts of an unwanted impurity were also found in these batches. If you want more information or wish to speak to one of our attorneys, please provide us with the. (Gray News) - Torrent Pharmaceuticals has expanded the recall of losartan potassium to include eight additional lots, according to the Food and Drug Administration. The report further added that the company is facing proposed class action in New Jersey Federal Court. The FDA issued a recall for Losartan. related to using the recalled losartan. Doctors prescribe Losartan to treat hypertension, hypertensive patients with left ventricular hypertrophy and nephropathy in Type 2 diabetic patients. In … Teva. in India has announced a recall of 87 lots of losartan potassium tablets (25 mg, 50 mg and 100 mg). FDA Losartan Recall - November 8, 2018. As more recalls on popular blood pressure medications rollout, users should check their prescriptions bottles and see if their medication has been recalled. On May 4, Vivimed Life Sciences Pvt Ltd recalled 19 lots of losartan potassium tablets in 25 mg, 50 mg and 100 mg doses. Losartan potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and “>” on the other side. The recalled tablets, made by Hetero Labs Ltd. Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs.